Centrose funding may be shift in biotech sector
Journal Sentinel, 9.29.07
A grant received by Centrose LLC highlights the growing cluster of companies in Madison aiming to develop new drugs in areas like cancer and neurodegenerative and heart disease.
Centrose said Friday it has received a $160,000 grant from the National Cancer Institute to continue developing its lead anti-cancer drug program. The company, based in Madison, is using sugar chemistry to work with a variety of existing and failed drugs to make them less toxic and more
effective.
Many University of Wisconsin-Madison researchers have received grants from the cancer institute, but more companies in the area are getting them now, said Tom Still, president of the Wisconsin Technology Council.
A grant received by Centrose LLC highlights the growing cluster of companies in Madison aiming to develop new drugs in areas like cancer and neurodegenerative and heart disease.
Centrose said Friday it has received a $160,000 grant from the National Cancer Institute to continue developing its lead anti-cancer drug program. The company, based in Madison, is using sugar chemistry to work with a variety of existing and failed drugs to make them less toxic and more
effective.
Many University of Wisconsin-Madison researchers have received grants from the cancer institute, but more companies in the area are getting them now, said Tom Still, president of the Wisconsin Technology Council.